Motohiko Tanaka

Interferon Therapy Reduces the Risk for Hepatocellular Carcinoma: National Surveillance Program of Cirrhotic and Noncirrhotic Patients with Chronic Hepatitis C in Japan

Haruhiko Yoshida, Yasushi Shiratori, Mitsuhiko Moriyama et al. · Annals of Internal Medicine · 1999 · 1.1K citations

Medicine, Oncology, Cancer Control +16

Cys34-Cysteinylated Human Serum Albumin Is a Sensitive Plasma Marker in Oxidative Stress-Related Chronic Diseases

Kohei Nagumo, Motohiko Tanaka, Victor Tuan Giam Chuang et al. · PLoS ONE · 2014 · 199 citations · Full text

Pharmacy, Biochemistry, Analytical Toxicology +6

Coinfection of hepatitis C virus in patients with chronic hepatitis B infection

Shinjiro Sato, Shigetoshi Fujiyama, Motohiko Tanaka et al. · Journal of Hepatology · 1994 · 155 citations

Life Sciences, Infectious Diseases, Microbiology +9

Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon

Masafumi Ikeda, Shigetoshi Fujiyama, Motohiko Tanaka et al. · Journal of Gastroenterology · 2005 · 132 citations

Medicine, Immunology, Oncology +14

Transcatheter Arterial Chemotherapy with and without Embolization in Patients with Hepatocellular Carcinoma

Masafumi Ikeda, Seishi Maeda, Junji Shibata et al. · Oncology · 2004 · 88 citations

Medicine, Oncology, Pharmacology +13